Non-genomic glucocorticoid effects to provide the basis for new drug developments.
about
Glucocorticoid receptor signaling in health and diseaseThe supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritisGlucocorticoid-dependent hippocampal transcriptome in male rats: pathway-specific alterations with agingSteroid and oxygen effects on eIF4F complex, mTOR, and ENaC translation in fetal lung epitheliaSteroid receptor expression in the fish inner ear varies with sex, social status, and reproductive state.AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death.ACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma.Stress-Related and Circadian Secretion and Target Tissue Actions of Glucocorticoids: Impact on Health.Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatasesThe effect of intravenous Dexamethasone on post-cesarean section pain and vital signs: A double-blind randomized clinical trial.Multiple distinct stimuli increase measured nucleosome occupancy around human promotersEffective analgesic dose of dexamethasone after painless abortionInhibition of proliferation, migration and proteolysis contribute to corticosterone-mediated inhibition of angiogenesisCellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids.Glucocorticoid receptor localizes to adherens junctions at the plasma membrane of keratinocytes.Tissue expression of steroid hormone receptors is associated with differential immune responsiveness.Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis.Helix 8 of the ligand binding domain of the glucocorticoid receptor (GR) is essential for ligand binding.The importance of biological oscillators for hypothalamic-pituitary-adrenal activity and tissue glucocorticoid response: coordinating stress and neurobehavioural adaptation.Rapid Glucocorticoid Feedback Inhibition of ACTH Secretion Involves Ligand-Dependent Membrane Association of Glucocorticoid Receptors.Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling.Stress-induced redistribution of immune cells--from barracks to boulevards to battlefields: a tale of three hormones--Curt Richter Award winner.Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors.The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore.Brain-immune communication psychoneuroimmunology of multiple sclerosis.Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation.Neuroendocrine factors alter host defense by modulating immune function.The glucocorticoid receptor signalling in breast cancer.The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.Tissue-specific glucocorticoid action: a family affair.Nongenomic glucocorticoid effects on activity-dependent potentiation of catecholamine release in chromaffin cells.Minireview: live and let die: molecular effects of glucocorticoids on bone cells.Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer.Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids.Non-genomic effect of glucocorticoids on cardiovascular system.Systemic use of non-biologic corticosteroids in orofacial diseases.The actin cytoskeleton in rapid steroid hormone actions.Pharmacology of intra-articular triamcinolone.Chrousos syndrome: from molecular pathogenesis to therapeutic management.
P2860
Q26828358-28832729-931E-4D98-84E4-8FAC68D17EFEQ28084878-F3ACD823-05FE-4B31-9F18-67FBA80283C6Q28385751-E9390FC0-B568-497E-B481-0F94E6A38C62Q28594930-27F0C36D-065F-4F68-8CB7-4644E21A1D5FQ30481390-EC9D2D3F-6B5A-444D-A2D6-1BA250B60FEFQ33455297-C33E18BA-6E7C-498C-A058-619C24A5A5D6Q33586715-AC4C186A-60BA-46D5-BCF4-AD56A9194F22Q33611461-9957FD3F-10E6-4315-A56B-4188F24112F2Q33636430-1F3E5B33-81EF-4983-B56E-F2AEBAB47747Q33828059-D0CCDF44-6748-4AE4-9839-E47230CB007DQ33997209-FEA3C0DF-0D46-4519-BA2E-739027C5A302Q34167140-48E79D79-007C-4660-AD1C-D2C7FB22AC60Q34441751-662727B4-DFA5-47FF-B8BC-FE691476EB1AQ34536741-8B5DCE94-C028-4205-93A2-57774EABE4ADQ34707135-841BD4F2-A5C7-4C8C-A8EE-A3971CECC162Q34775073-D62A92CF-F727-4369-84D8-22407227545DQ35544526-05E01240-9D04-479A-BA14-14266AA7156FQ35562762-781BFCD0-9CF2-4598-A758-1014D8052DC3Q35964417-488BD4D1-9E3A-421D-93D1-A7C62D62AD5CQ35970904-7F365CF8-7F6E-4708-96ED-78F440F4CE84Q36094422-507C5F0F-01C9-4A88-A052-B272A42C325CQ36143936-FF73B1C5-4979-4DFB-BC6D-4980548E6681Q36673022-65F15B48-E504-4F0B-BAC7-769DF44E3105Q36838985-399E2702-7305-48F5-9BCF-8BB763DC16CEQ36888160-21692448-999D-47B3-A2A2-E410665F4CA8Q36946327-8793F85D-5E0F-45BF-A5DD-8769C89723DAQ36964735-4BB277B5-A01D-446C-9552-18864F17C27FQ36990011-377D61C5-FBC5-4896-AA7C-27267F511449Q37021452-C19C7ED6-23E3-4223-A4D8-2D1422DE42A8Q37257579-ECFEDA68-24E1-4DEE-AADC-F5A336397030Q37274908-9136AD1B-4ACC-41CF-ACCF-772A34D5FFB2Q37325264-4A9ED868-F235-4D9B-99B2-E959D6213BFFQ37499649-5C81E93E-7F76-4F48-91F4-5939662278A6Q37720884-A35CCCB4-094C-455E-8038-B63EB7F937B4Q37756178-2E1A6440-5BCC-4A05-9DF4-82AEB0F61D5DQ38045751-F8163FF3-5C75-42F0-B718-44721E93FA9AQ38112826-E47F5AC5-A94E-4587-8A34-1AF495518C0CQ38195010-8B8C5C2E-FFCE-4F8C-A27C-3E5B9A2E2343Q38211488-B9DA36B6-4918-4D94-BF10-12DBD40E979CQ38365216-9AB991B6-FD29-4CFF-AE8D-0EC60B517B88
P2860
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
@ast
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
@en
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
@nl
type
label
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
@ast
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
@en
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
@nl
prefLabel
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
@ast
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
@en
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
@nl
P1476
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
@en
P2093
In-Ho Song
P304
P356
10.1016/J.MCE.2005.11.012
P577
2006-01-18T00:00:00Z